Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Zip Device to Conventional Sutures for Laceration Repair in Pediatrics in an Emergency Department (ZIPPED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04122859
Recruitment Status : Recruiting
First Posted : October 10, 2019
Last Update Posted : October 10, 2019
Sponsor:
Information provided by (Responsible Party):
ZipLine Medical Inc.

Brief Summary:
A prospective, randomized, controlled post-market clinical investigation that will enroll pediatric subjects requiring laceration repair. The investigation population will consist of 30 subjects fulfilling the eligibility criteria for the clinical investigation. The subjects will be randomly assigned at a 1:1 ratio to either the Zip 4 Surgical Skin Closure Device group or the Standard of Care sutures group.

Condition or disease Intervention/treatment Phase
Laceration of Skin Device: Zip Skin Closure Device Not Applicable

Detailed Description:

The commercial use of the Zip device has demonstrated applicability and acceptance in many medical specialties, including laceration closure in the Emergency Department setting. However, while clinical studies have demonstrated quantitative performance benefits of the device in orthopedic, dermatology, cardiac and cardiology specialties, no quantitative studies have been conducted in the Emergency Department setting with the device with which emergency medicine physicians may make quantitative, informed treatment choices. The Sponsor (ZipLine Medical) and the study doctor (investigator) have furthermore identified the pediatric patient population presenting for laceration repair in the Emergency Department as a group that may uniquely benefit from the use of the Zip device.

Standard care for wounds of this type require cleaning the wound, anesthetizing the wound and closing the wound with sutures that typically require subsequent removal at a later date. The Zip device is non-invasive and therefore requires no injected anesthesia or sedation for wound closure. In addition, the referenced clinical studies have demonstrated at least a 3 times speed advantage over sutures. The Zip device ease of use and consistency of outcomes enables less skilled or experienced caregivers to perform fast, efficient and excellent wound closure, which can improve department and staff efficiency, patient throughput and overall patient satisfaction. Finally, the Zip device may be removed by the patient or parent at home, eliminating a return-to-clinic visit for removal.

ZipLine Medical believes that the demonstrated benefits of the Zip device will be more pronounced with the specified pediatric population due to reduced procedure time, elimination of injected anesthesia and elimination of a return visit for suture removal. ZipLine Medical believes that this will reduce fear and anxiety in pediatric patients. Furthermore, ZipLine Medical believes that the Zip device can improve Emergency Department efficiency and patient throughput, reduce overall healthcare cost and improve overall patient (and parent) satisfaction.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A prospective, randomized, controlled post-market clinical investigation that will enroll pediatric subjects requiring laceration repair. The investigation population will consist of 30 pediatric subjects fulfilling the eligibility criteria for the clinical investigation. The subjects will be randomly assigned at a 1:1 ratio to either the Zip 4 Surgical Skin Closure Device group or the Standard of Care sutures group.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Controlled, Post-market Clinical Investigation to Evaluate Zip Surgical Skin Closure Device in Comparison of Using Standard of Care Sutures for Laceration Repair in Pediatrics in an Emergency Department
Actual Study Start Date : November 1, 2018
Estimated Primary Completion Date : July 1, 2020
Estimated Study Completion Date : July 31, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Zip Skin Closure Device
The device is a class IIa device as per Annex II of the MDD 93/42EEC, as amended by Directive 2007/47/EEC. A CE-mark was affixed in 2014. The Zip device adheres to the skin adjacent to an incision or laceration by use of pressure-sensitive skin adhesives. A combination of acrylic and hydrocolloid adhesives is used to provide a skin-friendly environment while providing the necessary tack to maintain skin adhesion during a maximum wear time of 14 days. In addition to the pressure-sensitive adhesives, the device's closure and force distribution components are made up of polyurethane monofilm, polyethylene tape, polyester and nylon.
Device: Zip Skin Closure Device
The device is a CE-marked, single use, sterile medical device that is designed to provide closure speed superior to sutures, while resulting in a suture-like cosmetic outcome. It adheres to the skin adjacent to an incision or laceration by use of pressure-sensitive skin adhesives.

Active Comparator: Standard of Care Sutures
Conventional sutures used for laceration repair
Device: Zip Skin Closure Device
The device is a CE-marked, single use, sterile medical device that is designed to provide closure speed superior to sutures, while resulting in a suture-like cosmetic outcome. It adheres to the skin adjacent to an incision or laceration by use of pressure-sensitive skin adhesives.




Primary Outcome Measures :
  1. Mean difference in time to wound closure of the Zip 4 Surgical Skin Closure Device in comparison to conventional sutures used in a pediatric population presenting for laceration repair. [ Time Frame: Intra operative ]
    These include total treatment time and duration of period starting from the preparation of procedure until protective wound dressing is applied, and including whether or not anesthesia and/or sedation was used when comparing the Zip 4 Surgical Skin Closure Device and the standard of care closure suturing


Secondary Outcome Measures :
  1. Difference in Wound Evaluation Score (WES) [ Time Frame: 10 days and 30 days post laceration repair ]
    A Wound Evaluation Score will be documented by an independent reviewer of photos taken at Day 0 and compared to 10 Day and 30 Day to evaluate the satisfaction and outcomes of the Zip 4 Surgical Skin Closure Device in comparison to conventional sutures used in a pediatric population presenting for laceration repair. The WES evaluates six clinical variables including incision edges, contour irregularity, width, edge inversion, inflammation and overall cosmesis. A score of 6 is considered optimal, while a score of < or =5 suboptimal.

  2. Satisfaction of Rate of Wound Healing of Laceration Repair:satisfaction rating [ Time Frame: 30 days post laceration repair ]
    Parents of patients will document the rate of wound healing satisfaction in subject post-treatment. The satisfaction rating for the Zip 4 Surgical Skin Closure Device will be compared to conventional sutures used in a pediatric population for laceration repair. The questionnaire will contain questions where the parent either will mark the most correct answer or rate on a line between 0 (Very Satisfied) to 100 (Very Dissatisfied) mm.

  3. Pain Level for Wound Healing of Laceration Repair: visual analog scale (VAS) [ Time Frame: Day 0 and 10 days post laceration repair ]
    Parents of patients will document the level of pain the patient experiences in connection to the Zip 4 Surgical Skin Closure Device and conventional sutures application and removal used in a pediatric population for laceration repair by a visual analog scale (VAS) 0 (No Pain) -100 (Worst Pain) mm

  4. Safety by Adverse Events reported that relate to the study device [ Time Frame: Intra operative through the end of the study at 30 days post laceration repair ]
    The incidence and severity of adverse events associated with the Zip 4 Surgical Skin Closure Device and Standard of Care closure sutures.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Between 4 to 14 years of age at the time of laceration repair.
  2. Require suture closure as standard of care for simple straight wounds on trunk or extremities up to 4 cm long.
  3. Low Tension Laceration, e.g. skin can be easily approximated by pinching with fingers.
  4. Subject and legal representative(s) are willing and able to comply with the investigational device removal and meet the follow up visit requirements.
  5. Subject and legal representative(s) have been informed of the nature, the scope and the relevance of the study.
  6. Subject and legal representative(s) have voluntarily agreed to participation and have duly signed the Informed Consent Form.

Exclusion Criteria:

  1. Known personal or familial history of scar hypertrophy.
  2. Known or suspected allergies or hypersensitivity to non-latex skin adhesives.
  3. Atrophic skin deemed clinically prone to blistering.
  4. Wounds that are easily susceptible to infection as a result of exposure to unsanitary conditions ("dirty wounds").
  5. Wounds that require deep dermal closure using sutures.
  6. Known or suspected mental problems and/or aggressiveness that indicates that the subject might try to remove the device during the treatment period.
  7. Participating in any other clinical investigation.
  8. Known health condition that would affect healing in the opinion of the investigator.
  9. Any subject that according to the Declaration of Helsinki is deemed unsuitable for study enrollment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04122859


Contacts
Layout table for location contacts
Contact: Eric Storne 408.684.0747 estorne@ziplinemedical.com

Locations
Layout table for location information
Israel
Kaplan Medical Center Recruiting
Reẖovot, Israel
Contact: Uri Balla, MD    +972-52-2326141    Uribal@clalit.org.il   
Sponsors and Collaborators
ZipLine Medical Inc.
Investigators
Layout table for investigator information
Principal Investigator: Uri Balla, MD Kaplan Medical Center, Eehovot Israel
  Study Documents (Full-Text)

Documents provided by ZipLine Medical Inc.:
Study Protocol  [PDF] July 13, 2018


Layout table for additonal information
Responsible Party: ZipLine Medical Inc.
ClinicalTrials.gov Identifier: NCT04122859     History of Changes
Other Study ID Numbers: 012
First Posted: October 10, 2019    Key Record Dates
Last Update Posted: October 10, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by ZipLine Medical Inc.:
Pediatrics
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Lacerations
Disease Attributes
Pathologic Processes
Wounds and Injuries